Entero Therapeutics names new interim CEO after leadership change

Go back to Entero Therapeutics names new interim CEO after leadership change

Form 8-K Entero Therapeutics, For: Sep 09

September 9, 2025 5:00 PM EDT

false 0001604191 0001604191 2025-09-09 2025-09-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares... More